Cre-Controlled CRISPR mutagenesis provides fast and easy conditional gene inactivation in zebrafish.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
18 02 2021
Historique:
received: 05 09 2020
accepted: 22 01 2021
entrez: 19 2 2021
pubmed: 20 2 2021
medline: 7 4 2021
Statut: epublish

Résumé

Conditional gene inactivation is a powerful tool to determine gene function when constitutive mutations result in detrimental effects. The most commonly used technique to achieve conditional gene inactivation employs the Cre/loxP system and its ability to delete DNA sequences flanked by two loxP sites. However, targeting a gene with two loxP sites is time and labor consuming. Here, we show Cre-Controlled CRISPR (3C) mutagenesis to circumvent these issues. 3C relies on gRNA and Cre-dependent Cas9-GFP expression from the same transgene. Exogenous or transgenic supply of Cre results in Cas9-GFP expression and subsequent mutagenesis of the gene of interest. The recombined cells become fluorescently visible enabling their isolation and subjection to various omics techniques. Hence, 3C mutagenesis provides a valuable alternative to the production of loxP-flanked alleles. It might even enable the conditional inactivation of multiple genes simultaneously and should be applicable to other model organisms amenable to single integration transgenesis.

Identifiants

pubmed: 33602923
doi: 10.1038/s41467-021-21427-6
pii: 10.1038/s41467-021-21427-6
pmc: PMC7893016
doi:

Substances chimiques

RNA, Messenger 0
Green Fluorescent Proteins 147336-22-9
Monophenol Monooxygenase EC 1.14.18.1
Cre recombinase EC 2.7.7.-
Integrases EC 2.7.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1125

Références

Dev Genes Evol. 2001 Mar;211(3):150-3
pubmed: 11455427
Genesis. 2012 Oct;50(10):750-7
pubmed: 22522888
Nature. 2012 Nov 1;491(7422):114-8
pubmed: 23000899
Cold Spring Harb Protoc. 2012 Aug 01;2012(8):
pubmed: 22854565
Immunity. 2018 May 15;48(5):835-836
pubmed: 29768166
Nat Commun. 2019 Nov 29;10(1):5454
pubmed: 31784531
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13904-9
pubmed: 23918387
Development. 2014 Oct;141(19):3807-18
pubmed: 25249466
Genetics. 2015 Jun;200(2):431-41
pubmed: 25855067
Nat Rev Genet. 2005 Jun;6(6):507-12
pubmed: 15931173
Annu Rev Virol. 2015 Nov;2(1):25-40
pubmed: 26958905
Handb Exp Pharmacol. 2007;(178):3-28
pubmed: 17203649
Genome Res. 2014 Jan;24(1):142-53
pubmed: 24179142
Nucleic Acids Res. 2019 Jul 2;47(W1):W171-W174
pubmed: 31106371
Sci Rep. 2018 Sep 6;8(1):13366
pubmed: 30190522
Lab Anim. 2020 Jun;54(3):213-224
pubmed: 31510859
Methods Cell Biol. 2004;77:201-22
pubmed: 15602913
Methods. 2006 Jul;39(3):207-11
pubmed: 16837210
PLoS One. 2015 Jun 17;10(6):e0129072
pubmed: 26083735
Development. 2000 May;127(9):1953-60
pubmed: 10751183
Trends Biotechnol. 2013 Jul;31(7):397-405
pubmed: 23664777
Nature. 1980 Oct 30;287(5785):795-801
pubmed: 6776413
Science. 1988 Jun 10;240(4858):1439-43
pubmed: 3287619
Elife. 2019 Oct 30;8:
pubmed: 31663848
Development. 2020 Jun 8;147(11):
pubmed: 32439756
Dev Cell. 2016 Mar 21;36(6):654-67
pubmed: 27003937
Development. 2011 Nov;138(22):4831-41
pubmed: 22007133
Dev Biol. 1976 Mar;49(1):220-35
pubmed: 943345
Cell Tissue Res. 2018 Apr;372(1):41-50
pubmed: 29435650
Dev Cell. 2018 Jul 2;46(1):112-125.e4
pubmed: 29974860
Sci Rep. 2017 Mar 31;7(1):517
pubmed: 28364122
PLoS Genet. 2018 Nov 14;14(11):e1007754
pubmed: 30427827
Nature. 2019 Apr;568(7751):193-197
pubmed: 30944477
Front Neural Circuits. 2014 May 06;8:41
pubmed: 24834028
PLoS Genet. 2017 Jul 13;13(7):e1006780
pubmed: 28704371
Nat Methods. 2015 Jun;12(6):535-40
pubmed: 25867848
Mol Genet Genomics. 2020 Jul;295(4):911-922
pubmed: 32367255
Dev Dyn. 2011 Jan;240(1):108-15
pubmed: 21117149
Genetics. 1974 May;77(1):71-94
pubmed: 4366476
Dev Cell. 2015 Mar 23;32(6):756-64
pubmed: 25752963
Science. 1970 Nov 13;170(3959):695-706
pubmed: 5479624
Dev Dyn. 2013 Aug;242(8):949-963
pubmed: 23723152
Nat Biotechnol. 2019 Mar;37(3):224-226
pubmed: 30809026
Biosci Rep. 2018 Sep 20;38(5):
pubmed: 30209206
Sci Rep. 2018 Apr 4;8(1):5647
pubmed: 29618800
Development. 2012 Nov;139(22):4099-103
pubmed: 23093421

Auteurs

Stefan Hans (S)

Center for Molecular and Cellular Bioengineering (CMCB), Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany. stefan.hans@tu-dresden.de.

Daniela Zöller (D)

Center for Molecular and Cellular Bioengineering (CMCB), Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.

Juliane Hammer (J)

Center for Molecular and Cellular Bioengineering (CMCB), Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.

Johanna Stucke (J)

Center for Molecular and Cellular Bioengineering (CMCB), Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.

Sandra Spieß (S)

Center for Molecular and Cellular Bioengineering (CMCB), Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.

Gokul Kesavan (G)

Center for Molecular and Cellular Bioengineering (CMCB), Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.

Volker Kroehne (V)

Center for Molecular and Cellular Bioengineering (CMCB), Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.

Juan Sebastian Eguiguren (JS)

Center for Molecular and Cellular Bioengineering (CMCB), Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.

Diana Ezhkova (D)

Center for Molecular and Cellular Bioengineering (CMCB), Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.

Andreas Petzold (A)

Center for Molecular and Cellular Bioengineering (CMCB), DRESDEN-Concept Genome Center, Technische Universität Dresden, Dresden, Germany.

Andreas Dahl (A)

Center for Molecular and Cellular Bioengineering (CMCB), DRESDEN-Concept Genome Center, Technische Universität Dresden, Dresden, Germany.

Michael Brand (M)

Center for Molecular and Cellular Bioengineering (CMCB), Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany. michael.brand@tu-dresden.de.

Articles similaires

Humans Meals Time Factors Female Adult

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

Classifications MeSH